Gut microbiota and metabolite signatures predict severe immune-related adverse events in advanced hepatobiliary cancers

Patients with severe irAEs exhibited unique changes in microbiota-fungi-metabolite interactions. Gut microbiota- and/or metabolite-based algorithms could be used as additional tools for predicting severe irAEs and as potential prognostic markers in advanced hepatobiliary cancers.